Phosphoinositide-3 kinase delta inhibitors (Bioway)

N/A

Report date: 2025/06/11 11:01:32
NME

Base Information

Drug NamePhosphoinositide-3 kinase delta inhibitors (Bioway)
Drug Alias NameBWC-101BWC-108
ClassificationSmall molecules
Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitors
TargetsPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsSolid tumoursPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioway Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioway Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A